AngioDynamics (NASDAQ:ANGO) Releases Earnings Results, Beats Estimates By $0.07 EPS

Posted by James Quigley on Jan 8th, 2025

AngioDynamics (NASDAQ:ANGO – Get Free Report) released its earnings results on Wednesday. The medical instruments supplier reported ($0.04) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.11) by $0.07, RTT News reports. AngioDynamics had a negative net margin of 83.95% and a negative return on equity of 5.86%. AngioDynamics updated its FY 2025 guidance to -0.380–0.340 EPS.

AngioDynamics Price Performance

NASDAQ ANGO opened at $9.40 on Wednesday. The stock’s 50-day moving average is $7.82 and its two-hundred day moving average is $7.27. AngioDynamics has a fifty-two week low of $5.26 and a fifty-two week high of $9.63. The firm has a market cap of $381.96 million, a P/E ratio of -1.54 and a beta of 0.59.

Wall Street Analysts Forecast Growth

A number of research firms have recently weighed in on ANGO. HC Wainwright reissued a “buy” rating and set a $14.00 price target on shares of AngioDynamics in a research report on Tuesday, December 10th. Canaccord Genuity Group reduced their price target on shares of AngioDynamics from $13.00 to $12.00 and set a “buy” rating for the company in a report on Friday, October 4th.

View Our Latest Analysis on ANGO

About AngioDynamics

(Get Free Report)

AngioDynamics, Inc, a medical technology company, engages in the design, manufacture, and sale of medical, surgical, and diagnostic devices for the use in treating peripheral vascular disease, and oncology and surgical settings in the United States and internationally. The company offers Auryon Atherectomy system that is designed to deliver an optimized wavelength, pulse width, and amplitude to remove lesions while preserving vessel wall endothelium.